Takeda Pharmaceutical Co - ADR Live Stock Price Today, Share Analysis and Chart

Name: Takeda Pharmaceutical Co - ADR: Is Infosys Ltd. worth buying?
Item: Takeda Pharmaceutical Co - ADR
Rating: 2.563597375
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, whi...

15.15 -0.01 (-0.07%)

Near 52W High of $15.56

2.7M

XNYS Volume

XNYS 03 Sep, 2025 4:00 PM (EDT)

High Financial Strength

55.6 / 100

Mid Valuation

31.2 / 100

Technically Moderately Bullish

62.8 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM

1Yr Price target upside is 16%

3 analysts

Takeda Pharmaceutical Co ADR Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..